一品红：艾司奥美拉唑镁肠溶干混悬剂获注册证书

Core Viewpoint - The company has received approval from the National Medical Products Administration for the drug registration certificate of Esomeprazole Magnesium Enteric-coated Suspension, indicating a significant advancement in its product portfolio [1] Group 1: Company Developments - The company's wholly-owned subsidiary, Guangzhou Yipinhong Pharmaceutical Co., Ltd., has recently obtained the drug registration certificate for Esomeprazole Magnesium Enteric-coated Suspension [1] - Esomeprazole is a proton pump inhibitor and the S-isomer of Omeprazole, which specifically inhibits the H+-K+ ATPase in gastric parietal cells, blocking the final step of gastric acid secretion [1] Group 2: Product Information - Esomeprazole is converted into its active form in the acidic environment of gastric parietal cells, providing inhibition of both basal gastric acid secretion and stimulated gastric acid secretion [1]